FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361959223> ?p ?o ?g. }

• W4361959223 abstract "<div>Abstract<p><b>Purpose:</b> Methotrexate chemotherapy can be associated with neurologic complications during therapy and long-term neurologic deficits. This study evaluated demographic and clinical factors associated with incidence of methotrexate neurotoxicity and described the impact of neurotoxicity on acute lymphoblastic leukemia (ALL) therapy in pediatric patients.</p><p><b>Experimental Design:</b> Patients were enrolled between 2012 and 2017 from three pediatric cancer treatment centers in the United States. Medical records for suspected cases of methotrexate neurotoxicity, defined as an acute neurologic event following methotrexate therapy, were reviewed. Cox proportional hazards models were used to estimate the association between race/ethnicity and methotrexate neurotoxicity. Multivariable linear regression models compared treatment outcomes between patients with and without methotrexate neurotoxicity.</p><p><b>Results:</b> Of the 280 newly diagnosed patients enrolled, 39 patients (13.9%) experienced methotrexate neurotoxicity. Compared with non-Hispanic whites, Hispanic patients experienced the greatest risk of methotrexate neurotoxicity (adjusted HR, 2.43; 95% CI, 1.06–5.58) after accounting for sex, age at diagnosis, BMI <i>Z</i>-score at diagnosis, and ALL risk stratification. Patients who experienced a neurotoxic event received an average of 2.25 fewer doses of intrathecal methotrexate. Six of the 39 cases of neurotoxicity (15.4%) experienced relapse during the study period, compared with 13 of the 241 (2.1%) patients without neurotoxicity (<i>P</i> = 0.0038).</p><p><b>Conclusions:</b> Hispanic ethnicity was associated with increased risk of methotrexate neurotoxicity, which was associated with treatment modifications and relapse. Understanding the mechanism and predictors of methotrexate neurotoxicity is important to improving treatment outcomes in pediatric ALL. <i>Clin Cancer Res; 24(20); 5012–7. ©2018 AACR</i>.</p></div>" @default.
• W4361959223 created "2023-04-05" @default.
• W4361959223 creator A5006630838 @default.
• W4361959223 creator A5012842824 @default.
• W4361959223 creator A5018314699 @default.
• W4361959223 creator A5021233041 @default.
• W4361959223 creator A5035833002 @default.
• W4361959223 creator A5051061458 @default.
• W4361959223 creator A5060581468 @default.
• W4361959223 creator A5066345693 @default.
• W4361959223 creator A5075211978 @default.
• W4361959223 creator A5082305273 @default.
• W4361959223 date "2023-03-31" @default.
• W4361959223 modified "2023-10-14" @default.
• W4361959223 title "Data from Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients" @default.
• W4361959223 doi "https://doi.org/10.1158/1078-0432.c.6528947" @default.
• W4361959223 hasPublicationYear "2023" @default.
• W4361959223 type Work @default.
• W4361959223 citedByCount "0" @default.
• W4361959223 crossrefType "posted-content" @default.
• W4361959223 hasAuthorship W4361959223A5006630838 @default.
• W4361959223 hasAuthorship W4361959223A5012842824 @default.
• W4361959223 hasAuthorship W4361959223A5018314699 @default.
• W4361959223 hasAuthorship W4361959223A5021233041 @default.
• W4361959223 hasAuthorship W4361959223A5035833002 @default.
• W4361959223 hasAuthorship W4361959223A5051061458 @default.
• W4361959223 hasAuthorship W4361959223A5060581468 @default.
• W4361959223 hasAuthorship W4361959223A5066345693 @default.
• W4361959223 hasAuthorship W4361959223A5075211978 @default.
• W4361959223 hasAuthorship W4361959223A5082305273 @default.
• W4361959223 hasBestOaLocation W43619592232 @default.
• W4361959223 hasConcept C126322002 @default.
• W4361959223 hasConcept C143998085 @default.
• W4361959223 hasConcept C2779491297 @default.
• W4361959223 hasConcept C2781059491 @default.
• W4361959223 hasConcept C29730261 @default.
• W4361959223 hasConcept C50382708 @default.
• W4361959223 hasConcept C71924100 @default.
• W4361959223 hasConcept C90924648 @default.
• W4361959223 hasConceptScore W4361959223C126322002 @default.
• W4361959223 hasConceptScore W4361959223C143998085 @default.
• W4361959223 hasConceptScore W4361959223C2779491297 @default.
• W4361959223 hasConceptScore W4361959223C2781059491 @default.
• W4361959223 hasConceptScore W4361959223C29730261 @default.
• W4361959223 hasConceptScore W4361959223C50382708 @default.
• W4361959223 hasConceptScore W4361959223C71924100 @default.
• W4361959223 hasConceptScore W4361959223C90924648 @default.
• W4361959223 hasLocation W43619592231 @default.
• W4361959223 hasLocation W43619592232 @default.
• W4361959223 hasOpenAccess W4361959223 @default.
• W4361959223 hasPrimaryLocation W43619592231 @default.
• W4361959223 hasRelatedWork W1963737685 @default.
• W4361959223 hasRelatedWork W2047713955 @default.
• W4361959223 hasRelatedWork W2053943033 @default.
• W4361959223 hasRelatedWork W2054110146 @default.
• W4361959223 hasRelatedWork W2118793690 @default.
• W4361959223 hasRelatedWork W2166275288 @default.
• W4361959223 hasRelatedWork W2211989521 @default.
• W4361959223 hasRelatedWork W2516167102 @default.
• W4361959223 hasRelatedWork W2604628849 @default.
• W4361959223 hasRelatedWork W2890912410 @default.
• W4361959223 isParatext "false" @default.
• W4361959223 isRetracted "false" @default.
• W4361959223 workType "article" @default.